Delivery Order SPE2DB24D1205-SPE2DB24FCSNG
Award Date
7/8/24
Potential Completion Date
7/9/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.20 firm fixed-price delivery order is for the supply of GADAVIST 10 MMOL/10 ML VIAL 10ML, a medical product. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,337.79 firm fixed-price delivery order is for the supply of 4565188888 GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML, a medical product. The contract has an ultimate completion date of July 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award, valued at $1,501.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for GADAVIST 10 MMOL/10 ML VIAL 10ML, with an ultimate completion date of April 10, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,136.62. It is for the supply of GADAVIST 1 MMOL/ML BULK VIAL 30ML, a medical product. The contract has an ultimate completion date of May 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.20 firm fixed-price delivery order is for the medical product "GADAVIST 10 MMOL/10 ML VIAL 10ML" and has a completion date of June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the U.S. The contract is a delivery order worth $1,711.35 for the supply of Gadavist 1 mmol/mL bulk vials. The contract has an ultimate completion date of September 10, 2024 and is a firm fixed-price contract. AmerisourceBergen has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies for a wide range of...
This federal contract award, valued at $1,704.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,175,077 units of GADAVIST 1 MMOL/ML BULK VIAL 30ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 8, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Gadavist 10 MMOL/10 ML vials. The award, valued at $4,315.48, is a Firm Fixed Price Delivery Order with a completion date of June 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,239.87, is for the supply of Gadavist 10 MMOL/10 ML vials, with a period of performance through December 14, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $1,828.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gadavist, a 10 mL vial of a 10 mmol/mL solution, with a performance period ending on May 6, 2025. The contract is a delivery order and is priced on a firm fixed-price basis. It is not designated as a set-aside contract, indicating open competition....